Time Trends in the Incidence of Parkinson Disease.

IMPORTANCE Changes over time in the incidence of parkinsonism and Parkinson disease (PD) remain uncertain. OBJECTIVE To investigate secular trends (period effects) and birth cohort trends in the incidence of parkinsonism and PD over 30 years in a geographically defined American population. DESIGN, SETTING, AND PARTICIPANTS We used the medical records-linkage system of the Rochester Epidemiology Project to identify incidence cases of PD and other types of parkinsonism in Olmsted County, Minnesota, from 1976 to 2005. All cases were classified by a movement disorder specialist using defined criteria through the review of the complete medical records within the system. The analyses for this study were conducted between May 2015 and January 2016. MAIN OUTCOMES AND MEASURES Incidence rates of parkinsonism and PD over 30 years. We tested for secular trends (period effects) using negative binomial regression models and for birth cohort effects using age-period-cohort models. RESULTS Of 906 patients with parkinsonism, 501 were men, and the median age at onset was 74 years (interquartile range, 66-81 years). Of the 464 patients with PD, 275 were men, and the median age at onset was 73 years (interquartile range, 64-80 years). The overall incidence rates increased significantly over 30 years in men for both parkinsonism (relative risk [RR], 1.17 per decade; 95% CI, 1.03-1.33) and PD (RR, 1.24 per decade; 95% CI, 1.08-1.43). These trends were driven primarily by the older age groups. In particular, for men 70 years or older, incidence rates increased for both parkinsonism (RR, 1.24 per decade; 95% CI, 1.07-1.44) and PD (RR, 1.35 per decade; 95% CI, 1.10-1.65). The secular trends were not significant for women overall or in age strata. We observed an increased risk for both men and women born in the 1920 cohort (1915-1924). However, this birth cohort effect was significant only for PD and only in men. CONCLUSIONS AND REVELANCE Our study suggests that the incidence of parkinsonism and PD may have increased between 1976 and 2005, particularly in men 70 years and older. These trends may be associated with the dramatic changes in smoking behavior that took place in the second half of the 20th century or with other lifestyle or environmental changes. However, the trends could be spurious and need to be confirmed in other populations.

[1]  W. Rocca,et al.  Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism. , 2013, JAMA neurology.

[2]  I. Akushevich,et al.  Time trends of incidence of age-associated diseases in the US elderly population: Medicare-based analysis. , 2013, Age and ageing.

[3]  Kevin R. Sanft,et al.  Chemical exposures and Parkinson's disease: A population‐based case–control study , 2006, Movement disorders : official journal of the Movement Disorder Society.

[4]  Manjeet Singh,et al.  Environmental Exposure to Pesticides and Neurodegenerative Diseases , 2012 .

[5]  C. Tanner,et al.  Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 , 2007, Neurology.

[6]  V. Calabrese,et al.  PROJECTED NUMBER OF PEOPLE WITH PARKINSON DISEASE IN THE MOST POPULOUS NATIONS, 2005 THROUGH 2030 , 2007, Neurology.

[7]  B Carstensen,et al.  Age–period–cohort models for the Lexis diagram , 2007, Statistics in medicine.

[8]  B. Yawn,et al.  History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. , 2012, Mayo Clinic proceedings.

[9]  D. Maraganore,et al.  Time trends in the incidence of parkinsonism in Olmsted County, Minnesota , 2001, Neurology.

[10]  M. Goldacre,et al.  Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson’s disease and epilepsy in English populations 1979–2006 , 2010, Journal of Neurology.

[11]  M. Rossor,et al.  Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[12]  Scott M. Brue,et al.  Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. , 2012, International journal of epidemiology.

[13]  A. Singleton,et al.  Meeting Report: Consensus Statement—Parkinson’s Disease and the Environment: Collaborative on Health and the Environment and Parkinson’s Action Network (CHE PAN) Conference 26–28 June 2007 , 2008, Environmental health perspectives.

[14]  L. Escobedo,et al.  Smoking prevalence in US birth cohorts: the influence of gender and education. , 1996, American journal of public health.

[15]  M. Weisskopf,et al.  Age-period-cohort analysis of trends in amyotrophic lateral sclerosis in Denmark, 1970-2009. , 2013, American journal of epidemiology.

[16]  A. Ascherio,et al.  Variations in gender ratios support the connection between smoking and Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[17]  Walter A. Rocca,et al.  Risk factors for Parkinson's disease may differ in men and women: an exploratory study , 2013, Hormones and Behavior.

[18]  K. Walters,et al.  Time trends in incidence of Parkinson’s disease diagnosis in UK primary care , 2013, Journal of Neurology.

[19]  P Sandroni,et al.  Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.

[20]  D. Maraganore,et al.  Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990 , 1999, Neurology.

[21]  L. Lix,et al.  Socioeconomic variations in the prevalence and incidence of Parkinson's disease: a population-based analysis , 2009, Journal of Epidemiology & Community Health.

[22]  U. C. Bureau,et al.  Census of Population and Housing , 1993 .

[23]  F. Gutzwiller,et al.  Birth Cohort Effects in Neurological Diseases: Amyotrophic Lateral Sclerosis, Parkinson’s Disease and Multiple Sclerosis , 2012, Neuroepidemiology.

[24]  I Litvan,et al.  Consensus statement on the diagnosis of multiple system atrophy , 1998, Journal of the Neurological Sciences.

[25]  A. Stein,et al.  Early gestation as the critical time-window for changes in the prenatal environment to affect the adult human blood methylome , 2015, International journal of epidemiology.

[26]  E. Mulvey,et al.  Regression analyses of counts and rates: Poisson, overdispersed Poisson, and negative binomial models. , 1995, Psychological bulletin.

[27]  B. Boeve,et al.  Incidence of dementia with Lewy bodies and Parkinson disease dementia. , 2013, JAMA neurology.

[28]  D. Thurman,et al.  How common are the “common” neurologic disorders? , 2007, Neurology.

[29]  B. Yawn,et al.  American Journal of Epidemiology Practice of Epidemiology Use of a Medical Records Linkage System to Enumerate a Dynamic Population over Time: the Rochester Epidemiology Project , 2022 .

[30]  C. Griffiths,et al.  Trends in Parkinson’s disease related mortality in England and Wales, 1993–2006 , 2009, European journal of neurology.

[31]  M. Thun,et al.  Temporal relationship between cigarette smoking and risk of Parkinson disease , 2007, Neurology.

[32]  Mrc Psych,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop , 1996 .

[33]  B. Yawn,et al.  Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. , 2012, Mayo Clinic proceedings.

[34]  J. Dartigues,et al.  Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.